ZZUi0013-A 人诱导多能干细胞系 / BioVector® ZZUi0013-A Human Induced Pluripotent Stem Cell Line
- 价 格:¥599850
- 货 号:BioVector® ZZUi0013-A
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作微信:1843439339 (QQ同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
BioVector® ZZUi0013-A 人诱导多能干细胞系 / BioVector® ZZUi0013-A Human Induced Pluripotent Stem Cell Line
通用定义 / General Definition:
BioVector® ZZUi0013-A 是一种标准化的人源诱导多能干细胞 (iPSC) 系。该细胞系通常是由特定临床背景的供体(或健康对照)的体细胞,通过先进的非整合重编程技术(如塞内卡病毒或游离质粒)重编程而成。ZZUi 系列通常与特定的医学研究中心或大学(如郑州大学,Zhengzhou University)相关联。ZZUi0013-A 具有典型的多能性特征,能够无限增殖并分化为所有三个胚层的细胞。它为研究人类疾病的发病机制、药物筛选及发育生物学提供了高质量的细胞模型。
BioVector® ZZUi0013-A is a standardized human Induced Pluripotent Stem Cell (iPSC) line. This line is established from donor-derived somatic cells using advanced non-integrative reprogramming technologies (such as Sendai virus or episomal vectors). The ZZUi series is typically associated with specific clinical cohorts or academic institutions (e.g., Zhengzhou University). ZZUi0013-A exhibits classic pluripotency characteristics, including the capacity for infinite self-renewal and the potential to differentiate into cells of all three germ layers. It serves as a high-quality cellular model for investigating human disease mechanisms, drug screening, and developmental biology.
BioVector® ZZUi0013-A 技术说明书 (Technical Datasheet)
中文版说明书 (Chinese Datasheet)
1. 产品基本信息
产品名称: BioVector® ZZUi0013-A 人 iPSC 细胞系
供体 background: 详细的供体临床背景(如特定疾病表型或健康对照)。
重编程方法: 非整合型(Non-integrative),确保基因组中不含有外源载体序列。
特性验证: * 标志物: 强表达 OCT4, NANOG, SOX2, SSEA4。
核型: 具有正常的二倍体核型。
生长特性: 贴壁生长,集落边缘清晰。
2. 培养条件
维持培养基: BioVector® mTeSR Plus 或同级别无喂养层培养基。
基质包被:Matrigel 或 Laminin-511。
培养环境: 37 摄氏度,5% $CO_2$。
传代比例: 1:5 至 1:8,每 4-5 天传代一次。
3. 细胞应用
疾病建模: 若该系源自特定疾病患者,可用于模拟该疾病的细胞病理过程。
分化研究: 分化为功能性神经元、心肌细胞或类器官(Organoids)。
安全性筛选: 评估候选药物在人源背景下的潜在毒性。
4. 注意事项
细胞密度: 避免细胞过度汇合(Over-confluence),否则会增加自发分化的风险。
复苏建议: 复苏后前 24 小时建议使用含 ROCK 抑制剂 (Y-27632) 的培养基以提高存活率。
English Datasheet
1. General Product Information
Product Name: BioVector® ZZUi0013-A Human iPSC Line
Donor Profile: Detailed clinical background (e.g., specific disease phenotype or healthy control).
Reprogramming Method: Non-integrative, ensuring the host genome remains free of vector integration.
Characterization:
Markers: Strong expression of OCT4, NANOG, SOX2, and SSEA4.
Karyotype: Validated normal diploid karyotype.
Growth Properties: Adherent; forms well-defined, compact colonies.
2. Culture Conditions
Maintenance Medium: BioVector® mTeSR Plus or equivalent feeder-free system.
Coating Substrate:Matrigel or Laminin-511.
Incubation: 37 degrees Celsius, 5% $CO_2$.
Subculturing: 1:5 to 1:8 ratio; typically passaged every 4–5 days.
3. Applications
Disease Modeling: If derived from a specific patient, it serves to model the cytopathological processes of that disease.
Lineage Differentiation: Differentiation into functional neurons, cardiomyocytes, or 3D organoids.
Safety Pharmacology: Evaluating the toxicological profile of drug candidates in a human-specific genetic context.
4. Key Usage Notes
Differentiation Control: Monitor the culture daily for spontaneous differentiation. Differentiated areas should be removed prior to passaging.
Thawing Protocol: BioVector® recommends including a ROCK inhibitor (Y-27632) in the medium for the first 24 hours post-thaw to significantly improve cell attachment and viability.
注意 / Note: BioVector® ZZUi0013-A 应在生物安全二级 (BSL-2) 条件下操作。该细胞系对营养供应较为敏感,建议严格按照 BioVector® 推荐的换液频率进行维护。
BioVector® ZZUi0013-A should be handled under Biosafety Level 2 (BSL-2) conditions. The line is sensitive to nutrient fluctuations; BioVector® recommends strict adherence to the feeding schedule to maintain optimal pluripotency.
BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
电话:400-800-2947
工作QQ/微信同号:1843439339
网址
- 公告/新闻




